Ertapenem Injection and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Ertapenem Injection and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ertapenem
Brand name: Invanz, INVanz ADD-Vantage
Synonyms: Ertapenem
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ertapenem Injection-Insulin glargine, recombinant Subcutaneous
- Ertapenem Injection-Insulin glulisine
- Ertapenem Injection-Insulin Glulisine (Cartridges and Pens)
- Ertapenem Injection-Insulin Glulisine (Vials)
- Ertapenem Injection-Insulin glulisine Subcutaneous
- Ertapenem Injection-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Ertapenem Sodium
- Insulin glargine and lixisenatide Subcutaneous-Ertugliflozin
- Insulin glargine and lixisenatide Subcutaneous-Ertugliflozin and metformin
- Insulin glargine and lixisenatide Subcutaneous-Ertugliflozin and sitagliptin
- Insulin glargine and lixisenatide Subcutaneous-Erwinaze
- Insulin glargine and lixisenatide Subcutaneous-Ery-Tab